Contract with Customer, Liability, Current of BridgeBio Pharma, Inc. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: BridgeBio Pharma, Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
BridgeBio Pharma, Inc. Contract with Customer, Liability, Current for the quarter ending 31 Dec 2025 was $7,190,000, a 51% decline year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Current, Quarterly (USD)

Contract with Customer, Liability, Current, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$7,190,000	-$7,414,000	-51%	31 Dec 2025	10-K	24 Feb 2026	2025	FY
Q3 2025	$9,087,000			30 Sep 2025	10-Q	29 Oct 2025	2025	Q3
Q4 2024	$14,604,000			31 Dec 2024	10-K	24 Feb 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.